ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,183.20
0.62%
S&P 500
5,308.13
0.09%
US Dollar vs CAD
1.36249
0.12%
Bitcoin
69,677.71
5.14%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zai Lab Ltd (ZLAB)

  7. Zai Lab Ltd (ZLAB) News

ZLAB Zai Lab Ltd

20.84
1.44 (7.42%)
After Hours
Last Updated: 16:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Zai Lab Ltd ZLAB NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
1.44 7.42% 20.84 16:30:00
Open Price Low Price High Price Close Price Previous Close
19.93 19.93 21.07 20.84 19.40
more quote information »

Recent News

Date Time Source Heading
5/19/202423:21BWZai Lab and Innoviva Specialty Therapeutics Announce NMPA..
5/16/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/16/202406:30BWZai Lab Announces Participation in May and June Investor..
5/15/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/14/202412:22EDGAR2Form 144 - Report of proposed sale of securities
5/14/202406:30BWZai Lab Announces Acceptance of Supplemental Biologics..
5/12/202419:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
5/08/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:09EDGAR2Form 8-K - Current report
5/08/202415:05BWZai Lab Announces First Quarter 2024 Financial Results and..
4/15/202406:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
4/11/202406:30BWZai Lab Statement on Executive Management Team’s Agreement..
4/02/202406:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
4/01/202406:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
3/27/202408:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
3/13/202418:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
3/06/202415:01BWZai Lab to Present Final Overall Survival (OS) Data from..
3/06/202406:30BWZai Lab Announces Participation in March Investor Conference
3/04/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202415:12EDGAR2Form 8-K - Current report
2/27/202415:05BWZai Lab Announces Full-Year 2023 Financial Results and..
2/08/202415:37EDGAR2Form 8-K - Current report
1/25/202415:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
1/10/202416:12BWZai Lab Announces The New England Journal of Medicine..
1/03/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202414:50EDGAR2Form 144 - Report of proposed sale of securities
1/03/202414:47EDGAR2Form 144 - Report of proposed sale of securities
1/03/202414:42EDGAR2Form 144 - Report of proposed sale of securities
12/22/202315:29EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
12/19/202306:30BWZai Lab Announces Participation in January Investor..
12/18/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202307:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
12/12/202322:10BWZai Lab Announces the First Listing of VYVGART®..
11/16/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:10EDGAR2Form 8-K - Current report
11/07/202315:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
11/03/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202314:20EDGAR2Form 144 - Report of proposed sale of securities
10/26/202306:30GLOBEZai Lab Announces Participation in November Investor..
10/18/202306:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
10/03/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202306:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
9/08/202305:12EDGAR2Form 144 - Report of proposed sale of securities
8/30/202306:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
8/29/202306:38GLOBEZai Lab Announces Participation in September Investor..
8/21/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
ZLAB
Zai Lab
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved